Update on immunopathogenesis in inflammatory myopathies

Current Opinion in Rheumatology

Volumn 13, Issue 6, 2001, Pages 461-468

  Nagaraju, Kanneboyina ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL INFILTRATION; CELL INTERACTION; GENE THERAPY; HUMAN; INFLAMMATORY DISEASE; MYOPATHY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; T LYMPHOCYTE;

ANTIBODY FORMATION; APOPTOSIS; CHEMOKINES; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MATRIX METALLOPROTEINASES; MUSCLE, SKELETAL; MYOSITIS;

EID: 0035171361     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200111000-00002     Document Type: Review

References (40)

1. Update on myositis-specific and myositis-associated autoantibodies
2. The immunobiology of muscle
3. The physiology of inflammatory myopathies: An overview
4. Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis
5. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells
6. Increased expression of interleukin 1 alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis
7. Dendritic cells
8. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-8, IL- 15, and monocyte chemoattractant protein-1 production
9. The expression of co-stimulatory and accessory molecules on cultured human muscle cells is not dependent on stimulus by pro-inflammatory cytokines: Relevance for the pathogenesis of inflammatory myopathy
10. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy
11. Cross-presentation, dendritic cells, tolerance and immunity
12. Immunological capabilities of skeletal muscle cells
13. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli
14. Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts
15. Cytokines and chemokines are both expressed by human myoblasts: Possible relevance for the immune pathogenesis of muscle inflammation
16. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions
17. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
18. CD86 (B7-2) can function to drive MHC-restricted antigen specific CTL responses in vivo
19. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies
20. Decreased expression of interleukin-1 alpha, interleukin-1 beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis
21. From the cover: Conditional upregulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies
22. HLA-G and HLA-E: Fundamental and pathophysiological aspects
23. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G
24. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders
25. Matrix metalloproteinases in tumor invasion and metastasis
26. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies
27. Expression of specific matrix metalloproteinases in inflammatory myopathies
28. New developments in the role of cytokines and chemokines in inflammatory myopathies
29. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies
30. Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies
31. The role of lymphotoxin, in pathogenesis of polymyositis
32. Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis
33. NF-kappaB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia
34. The inhibition of apoptosis in myositis and in normal muscle cells
35. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies
36. Bcl-2 related proteins, apoptosis and disease
37. Inhibition of Fas death signals by FLIPs
38. Cell death inhibition: Keeping caspases in check
39. Expression of human IAP-like protein in skeletal muscle: A possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies
40. T-cell anti-apoptotic mechanisms in inflammatory myopathies